G Bakker1, M W A Caan2, R S Schluter2, O J N Bloemen1, F da Silva-Alves3, M B de Koning3, E Boot4, W A M Vingerhoets1, D H Nieman3, L de Haan3, J Booij4, T A M J van Amelsvoort1. 1. Department of Psychiatry & Psychology,University of Maastricht,The Netherlands. 2. Department of Radiology,Academic Medical Center, University of Amsterdam,Amsterdam,The Netherlands. 3. Department of Psychiatry,Academic Medical Center, University of Amsterdam,Amsterdam,The Netherlands. 4. Department of Nuclear Medicine,Academic Medical Center, University of Amsterdam,Amsterdam,The Netherlands.
Abstract
BACKGROUND: Patients with a deletion at chromosome 22q11.2 (22q11DS) have 30% lifetime risk of developing a psychosis. People fulfilling clinical criteria for ultra-high risk (UHR) for psychosis have 30% risk of developing a psychosis within 2 years. Both high-risk groups show white-matter (WM) abnormalities in microstructure and volume compared to healthy controls (HC), which have been related to psychotic symptoms. Comparisons of WM pathology between these two groups may specify WM markers related to genetic and clinical risk factors. METHOD: Fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) were assessed using diffusion tensor magnetic resonance imaging (MRI), and WM volume with structural MRI, in 23 UHR patients, 21 22q11DS patients, and 33 HC. RESULTS: Compared to UHR patients 22q11DS patients had (1) lower AD and RD in corpus callosum (CC), cortical fasciculi, and anterior thalamic radiation (ATR), (2) higher FA in CC and ATR, and (3) lower occipital and superior temporal gyrus WM volume. Compared to HC, 22q11DS patients had (1) lower AD and RD throughout cortical fasciculi and (2) higher FA in ATR, CC and inferior fronto-occipital fasciculus. Compared to HC, UHR patients had (1) higher mean MD, RD, and AD in CC, ATR and cortical fasciculi, (2) no differences in FA. CONCLUSIONS: UHR and 22q11DS patients share a susceptibility for developing psychosis yet were characterized by distinct patterns of WM alterations relative to HC. While UHR patients were typified by signs suggestive of aberrant myelination, 22q11DS subjects showed signs suggestive of lower axonal integrity.
BACKGROUND:Patients with a deletion at chromosome 22q11.2 (22q11DS) have 30% lifetime risk of developing a psychosis. People fulfilling clinical criteria for ultra-high risk (UHR) for psychosis have 30% risk of developing a psychosis within 2 years. Both high-risk groups show white-matter (WM) abnormalities in microstructure and volume compared to healthy controls (HC), which have been related to psychotic symptoms. Comparisons of WM pathology between these two groups may specify WM markers related to genetic and clinical risk factors. METHOD: Fractional anisotropy (FA), axial diffusivity (AD), radial diffusivity (RD) and mean diffusivity (MD) were assessed using diffusion tensor magnetic resonance imaging (MRI), and WM volume with structural MRI, in 23 UHR patients, 21 22q11DS patients, and 33 HC. RESULTS: Compared to UHR patients 22q11DS patients had (1) lower AD and RD in corpus callosum (CC), cortical fasciculi, and anterior thalamic radiation (ATR), (2) higher FA in CC and ATR, and (3) lower occipital and superior temporal gyrus WM volume. Compared to HC, 22q11DS patients had (1) lower AD and RD throughout cortical fasciculi and (2) higher FA in ATR, CC and inferior fronto-occipital fasciculus. Compared to HC, UHR patients had (1) higher mean MD, RD, and AD in CC, ATR and cortical fasciculi, (2) no differences in FA. CONCLUSIONS: UHR and 22q11DS patients share a susceptibility for developing psychosis yet were characterized by distinct patterns of WM alterations relative to HC. While UHR patients were typified by signs suggestive of aberrant myelination, 22q11DS subjects showed signs suggestive of lower axonal integrity.
Authors: Carina Heller; Saskia Steinmann; James J Levitt; Nikos Makris; Kevin M Antshel; Wanda Fremont; Ioana L Coman; Stefan R Schweinberger; Thomas Weiß; Sylvain Bouix; Marek R Kubicki; Wendy R Kates; Zora Kikinis Journal: Schizophr Res Date: 2020-10-23 Impact factor: 4.939
Authors: Janneke R Zinkstok; Erik Boot; Anne S Bassett; Noboru Hiroi; Nancy J Butcher; Claudia Vingerhoets; Jacob A S Vorstman; Therese A M J van Amelsvoort Journal: Lancet Psychiatry Date: 2019-08-05 Impact factor: 27.083
Authors: Ania M Fiksinski; Maude Schneider; Clodagh M Murphy; Marco Armando; Stefano Vicari; Jaume M Canyelles; Doron Gothelf; Stephan Eliez; Elemi J Breetvelt; Celso Arango; Jacob A S Vorstman Journal: Am J Med Genet A Date: 2018-09-08 Impact factor: 2.802
Authors: David R Roalf; J Eric Schmitt; Simon N Vandekar; Theodore D Satterthwaite; Russell T Shinohara; Kosha Ruparel; Mark A Elliott; Karthik Prabhakaran; Donna M McDonald-McGinn; Elaine H Zackai; Ruben C Gur; Beverly S Emanuel; Raquel E Gur Journal: Psychiatry Res Neuroimaging Date: 2017-08-24 Impact factor: 2.376
Authors: Allysa Warling; Mani Yavi; Liv S Clasen; Jonathan D Blumenthal; François M Lalonde; Armin Raznahan; Siyuan Liu Journal: Cereb Cortex Date: 2021-10-22 Impact factor: 4.861
Authors: Geor Bakker; Matthan W A Caan; Wilhelmina A M Vingerhoets; Fabiana da Silva-Alves; Mariken de Koning; Erik Boot; Dorien H Nieman; Lieuwe de Haan; Oswald J Bloemen; Jan Booij; Thérèse A M J van Amelsvoort Journal: PLoS One Date: 2016-11-09 Impact factor: 3.240
Authors: Daniel S Tylee; Zora Kikinis; Thomas P Quinn; Kevin M Antshel; Wanda Fremont; Muhammad A Tahir; Anni Zhu; Xue Gong; Stephen J Glatt; Ioana L Coman; Martha E Shenton; Wendy R Kates; Nikos Makris Journal: Neuroimage Clin Date: 2017-05-11 Impact factor: 4.881
Authors: Julio E Villalón-Reina; Kenia Martínez; Xiaoping Qu; Christopher R K Ching; Talia M Nir; Deydeep Kothapalli; Conor Corbin; Daqiang Sun; Amy Lin; Jennifer K Forsyth; Leila Kushan; Ariana Vajdi; Maria Jalbrzikowski; Laura Hansen; Rachel K Jonas; Therese van Amelsvoort; Geor Bakker; Wendy R Kates; Kevin M Antshel; Wanda Fremont; Linda E Campbell; Kathryn L McCabe; Eileen Daly; Maria Gudbrandsen; Clodagh M Murphy; Declan Murphy; Michael Craig; Beverly Emanuel; Donna M McDonald-McGinn; Jacob A S Vorstman; Ania M Fiksinski; Sanne Koops; Kosha Ruparel; David Roalf; Raquel E Gur; J Eric Schmitt; Tony J Simon; Naomi J Goodrich-Hunsaker; Courtney A Durdle; Joanne L Doherty; Adam C Cunningham; Marianne van den Bree; David E J Linden; Michael Owen; Hayley Moss; Sinead Kelly; Gary Donohoe; Kieran C Murphy; Celso Arango; Neda Jahanshad; Paul M Thompson; Carrie E Bearden Journal: Mol Psychiatry Date: 2019-07-29 Impact factor: 15.992
Authors: Ida E Sønderby; Christopher R K Ching; Sophia I Thomopoulos; Dennis van der Meer; Daqiang Sun; Julio E Villalon-Reina; Ingrid Agartz; Katrin Amunts; Celso Arango; Nicola J Armstrong; Rosa Ayesa-Arriola; Geor Bakker; Anne S Bassett; Dorret I Boomsma; Robin Bülow; Nancy J Butcher; Vince D Calhoun; Svenja Caspers; Eva W C Chow; Sven Cichon; Simone Ciufolini; Michael C Craig; Benedicto Crespo-Facorro; Adam C Cunningham; Anders M Dale; Paola Dazzan; Greig I de Zubicaray; Srdjan Djurovic; Joanne L Doherty; Gary Donohoe; Bogdan Draganski; Courtney A Durdle; Stefan Ehrlich; Beverly S Emanuel; Thomas Espeseth; Simon E Fisher; Tian Ge; David C Glahn; Hans J Grabe; Raquel E Gur; Boris A Gutman; Jan Haavik; Asta K Håberg; Laura A Hansen; Ryota Hashimoto; Derrek P Hibar; Avram J Holmes; Jouke-Jan Hottenga; Hilleke E Hulshoff Pol; Maria Jalbrzikowski; Emma E M Knowles; Leila Kushan; David E J Linden; Jingyu Liu; Astri J Lundervold; Sandra Martin-Brevet; Kenia Martínez; Karen A Mather; Samuel R Mathias; Donna M McDonald-McGinn; Allan F McRae; Sarah E Medland; Torgeir Moberget; Claudia Modenato; Jennifer Monereo Sánchez; Clara A Moreau; Thomas W Mühleisen; Tomas Paus; Zdenka Pausova; Carlos Prieto; Anjanibhargavi Ragothaman; Céline S Reinbold; Tiago Reis Marques; Gabriela M Repetto; Alexandre Reymond; David R Roalf; Borja Rodriguez-Herreros; James J Rucker; Perminder S Sachdev; James E Schmitt; Peter R Schofield; Ana I Silva; Hreinn Stefansson; Dan J Stein; Christian K Tamnes; Diana Tordesillas-Gutiérrez; Magnus O Ulfarsson; Ariana Vajdi; Dennis van 't Ent; Marianne B M van den Bree; Evangelos Vassos; Javier Vázquez-Bourgon; Fidel Vila-Rodriguez; G Bragi Walters; Wei Wen; Lars T Westlye; Katharina Wittfeld; Elaine H Zackai; Kári Stefánsson; Sebastien Jacquemont; Paul M Thompson; Carrie E Bearden; Ole A Andreassen Journal: Hum Brain Mapp Date: 2021-02-21 Impact factor: 5.399